Comparison of injection site reactions and flu-like symptoms between users of peginterferon beta-1a and subcutaneous interferon beta-1a among persons with multiple sclerosis in the New York State Multiple Sclerosis Consortium

被引：0
|
作者：
Vaughn, C. [1 ,2 ,3 ]
Kavak, K. [1 ,3 ]
Bushra, A. [3 ]
Nadeem, M. [3 ]
Zakalik, K. [1 ,3 ]
Teter, B. [1 ]
Weinstock-Guttman, B. [1 ,2 ,3 ]
机构：
[1] New York State Multiple Sclerosis Consortium, Buffalo, NY USA
[2] SUNY Buffalo, Neurol, Buffalo, NY USA
[3] Jacobs MS Ctr Treatment & Res, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1806
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [41] Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Alteri, E.
    Kornmann, G.
    Moraga, M. Stam
    Casset-Semanaz, F.
    Miret, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S204 - S205
  • [42] Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis treated with peginterferon beta-1a or intramuscular interferon beta-1a in MS PATHS
    Hersh, Carrie M.
    Fitzgerald, Kathryn
    Ryerson, Lana Zhovtis
    Mowry, Ellen
    Liao, Shirley
    Altincatal, Arman
    Naylor, Maria
    NEUROLOGY, 2021, 96 (15)
  • [43] Assessing the Risk of Malignancy in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon beta-1a
    Sandberg-Wollheim, Magnhild
    Kornmann, Gabrielle
    Moraga, Margaretha Stam
    Miret, Montserrat
    Alteri, Enrica
    NEUROLOGY, 2010, 74 (09) : A61 - A62
  • [44] TITRATION OF INTRAMUSCULAR INTERFERON BETA-1A REDUCES THE SEVERITY AND INCIDENCE OF FLU-LIKE SYMPTOMS
    Matson, M.
    Zimmerman, T. R., Jr.
    Sperling, B.
    Tuccillo, D.
    Tang, T.
    Deykin, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 529 - 529
  • [45] The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
    Patten, SB
    Francis, G
    Metz, LM
    Lopez-Bresnahan, M
    Chang, P
    Curtin, F
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 175 - 181
  • [46] Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b
    Baum, K.
    O'Leary, C.
    Ferrer, F. Coret
    Klimova, E.
    Prochazkova, L.
    Bugge, J.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (09) : 1153 - 1160
  • [47] Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis
    Freedman, Mark S.
    Jack, Dominic
    Murgasova, Zuzana
    Todorovic, Milorad
    Seitzinger, Andrea
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [48] Interferon beta-1a and beta-1b for treatment of multiple sclerosis - Reply
    Durelli, L
    LANCET, 2002, 360 (9343): : 1428 - 1429
  • [49] Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis
    De Stefano, Nicola
    Curtin, Francois
    Stubinski, Bettina
    Blevins, Gregg
    Drulovic, Jelena
    Issard, Delphine
    Shotekov, Penko
    Gasperini, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 888 - 892
  • [50] A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
    Jaber, Amer
    Bozzato, Gian B.
    Vedrine, Lionel
    Prais, Wes A.
    Berube, Julie
    Laurent, Philippe E.
    BMC NEUROLOGY, 2008, 8 (1)
12345